Monthly Newsletter

AMSBIO has introduced GeneIn^TM - a new transfection reagent specifically designed to transfect stem cells and primary cells. Comparative studies against other commercially available reagents show GeneIn^TM to be superior in transfection efficiency with minimum cytotoxicity.

Delivery of nucleic acids into mammalian cells is often a critical task in the area of cell and molecular biology.  Stem cells and primary cells have traditionally proven to be very difficult to transfect.  GeneIn^TM is a novel cationic transfection reagent formulated from proprietary compounds that are chemically defined and are of animal-free origin.  Tested on a wide range of commonly used cell lines and operating over a wide dynamic range, GeneIn^TM offers minimal optimization to achieve superior expression results.
GeneIn^TM transfection reagent forms part of range of stem cell qualified products including leukemia inhibitory factor (mLIF) and fibroblast feeder cells that offer reproducible performance and high consistency from lot-to-lot.

For further information please click here or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized as a leading international provider of unique,  innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D culture, electrophoresis, glycobiology, post-translational modification & stem cell biology.